Clinical Applications of DNA Methylation Markers: Promises and Pitfalls



October 25, 2013

Colorectal cancer has predominantly been considered a genetic disease, characterized by sequential accumulation of genetic alterations. Growing evidence indicates that epigenetic alterations add an additional layer of complexity to the pathogenesis of colorectal cancer, and characterize a subgroup of colorectal cancers with a distinct etiology and prognosis. Here I discuss recent data on epigenetic regulation of gene expression in CRC and describe how the understanding of these processes will alter the management of colorectal cancer. I also discuss the challenges that we face in bringing epigenetic markers to the clinic.

Drug DiscoveryGenomicsInformatics

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.